Myasthenia Gravis Gets a New Drug Approval

(MedPage Today) — The FDA expanded the indication of inebilizumab (Uplizna) to include generalized myasthenia gravis (gMG), Amgen announced Friday.
The drug is now approved to treat gMG in adults who are anti-acetylcholine receptor (AChR) or…